Clonal architecture of telomere diseases [22-014160]
Ended Purchase Order Awarded
- Contract number
- 75N92022P00263
- Awardee
-
Archerdx LLC UEI NAG7RNTJQ5T8 Part of Invitae Corporation
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $82,098
Award facts
- Opportunity
-
- Clonal Architecture of Telomere Diseases Special Notice · 75N92022Q0442 · Posted Jul 29, 2022
- Contract value 100% obligated
- $82,097.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Boulder, CO 80301, USA
Award details come from SAM.gov/FPDS.
About this award
This is a $82,097.51 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Archerdx LLC, a subsidiary of Invitae Corporation. The contract is for CLONAL ARCHITECTURE OF TELOMERE DISEASES [22-014160] research, with a period of performance through August 10, 2023.
Archerdx is a genomic analysis company that has previously received federal contracts from NIH and the Defense Health Agency to provide DNA sequencing reagents, variant detection kits, and other products to support medical research, including in the areas of cancer, blood disorders, and infectious diseases. Invitae, Archerdx's parent company, is a genetic information company that has held numerous prime contracts with agencies like the Department of Veterans Affairs and Department of the Army to provide a range of genetic testing services and capabilities. This contract award does not utilize a set-aside designation.
Quick answers
Who was awarded contract 75N92022P00263?
75N92022P00263 was awarded to Archerdx LLC by National Heart Lung and Blood Institute (National Institutes of Health) on August 11, 2022.
How much is contract 75N92022P00263 worth?
The government has obligated $82,098 on 75N92022P00263.
Was contract 75N92022P00263 competed?
The extent of competition for 75N92022P00263 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award